Zinc Gluconate and the Common Cold: A Controlled Clinical Study
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
A report in 1984 on the success of zinc gluconate against common cold symptoms could not be confirmed in three subsequent studies, which are now known to have used formulations that inactivated zinc. A non-chelating formulation including glycine, which releases 93% of contained zinc into saliva, was tested in a randomized, placebo-controlled, double-blind trial in 73 young adults. Efficacy was recorded in symptom diaries using a symptom severity rating. Patients' symptoms first appeared 1.34 days prior to entry to the study in both groups. Disappearance of symptoms occurred after an additional 4.9 days for zinc-treated patients versus 6.1 days for placebo-treated patients. A difference was noted in the efficacy of treatment if it was started 1 day after symptom onset: cold duration was an additional 4.3 days in zinc-treated patients compared with 9.2 days for placebo-treated patients. Cough, nasal drainage and congestion were the symptoms most affected, and only mild side-effects were noted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study
Eby, G. A., Davis, D. R., & Halcomb, W. W. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.1.20 · Cited by 217
Douglas, R. M., Moore, B. W., Miles, H. B., Davies, L. M., Graham, N. M. H., Ryan, P., Worswick, D. A., & Albrecht, J. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601093140201 · Cited by 167
Curley, F. J., Irwin, R. S., Pratter, M. R., Stivers, D. H., Doern, G. V., Vernaglia, P. A., Larkin, A. B., & Baker, S. P. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.2.305 · Cited by 167
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds
Hayden, F. G., Kaiser, D. L., & Albrecht, J. K. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.2.224 · Cited by 70
Cited by
The Role of Zinc in Antiviral Immunity
Read, S. A., Obeid, S., Ahlenstiel, C., & Ahlenstiel, G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz013 · Cited by 749
ZINC AND THE RISK FOR INFECTIOUS DISEASE
Walker, C. F., & Black, R. E. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073054 · Cited by 491
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
Wessels, I., Rolles, B., & Rink, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01712 · Cited by 336
Singh, M., & Das, R. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001364.pub4 · Cited by 237
RetractedPrasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-4-200008150-00006 · Cited by 228
Metadata
- Authors
- Godfrey, J. C., Sloane, B. C., Smith, D. S., Turco, J. H., Mercer, N., & Godfrey, N. J.
- Venue
- Journal of International Medical Research
- Publisher
- SAGE Publications
- Published
- 1992-06
- Volume
- 20
- Issue
- 3
- Pages
- 234-246
- ISSN
- 0300-0605 (ISSN-L)
- 1473-2300
- OpenAlex
- W1939395730
- Cited by
- 90
- References
- 4
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.